1
|
Orel VE, Tselepi M, Mitrelias T, Rykhalskyi A, Romanov A, Orel VB, Shevchenko A, Burlaka A, Lukin S, Barnes CHW. Nanomagnetic Modulation of Tumor Redox State. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 2018; 14:1249-1256. [PMID: 29597047 DOI: 10.1016/j.nano.2018.03.002] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/20/2017] [Revised: 03/01/2018] [Accepted: 03/16/2018] [Indexed: 10/17/2022]
Abstract
Modulation of reactive oxygen and nitrogen species in a tumor could be exploited for nanotherapeutic benefits. We investigate the antitumor effect in Walker-256 carcinosarcoma of magnetic nanodots composed of doxorubicin-loaded Fe3O4 nanoparticles combined with electromagnetic fields. Treatment using the magnetic nanodot with the largest hysteresis loop area (3402 erg/g) had the greatest antitumor effect with the minimum growth factor 0.49 ± 0.02 day-1 (compared to 0.58 ± 0.02 day-1 for conventional doxorubicin). Electron spin resonance spectra of Walker-256 carcinosarcoma treated with the nanodots, indicate an increase of 2.7 times of free iron (that promotes the formation of highly reactive oxygen species), using the nanodot with the largest hysteresis loop area, compared to conventional doxorubicin treatment as well as increases in ubisemiquinone, lactoferrin, NO-FeS-proteins. Hence, we provide evidence that the designed magnetic nanodots can modulate the tumor redox state. We discuss the implications of these results for cancer nanotherapy.
Collapse
Affiliation(s)
- Valerii E Orel
- Medical Physics and Bioengineering Research Laboratory, National Cancer Institute, Kyiv, Ukraine; Biomedical Engineering Department, NTUU "Igor Sikorsky KPI", Kyiv, Ukraine.
| | - Marina Tselepi
- Cavendish Laboratory, University of Cambridge, United Kingdom; Department of Physics, University of Ioannina, Ioannina, Greece.
| | | | - Alexander Rykhalskyi
- Medical Physics and Bioengineering Research Laboratory, National Cancer Institute, Kyiv, Ukraine.
| | - Andriy Romanov
- Medical Physics and Bioengineering Research Laboratory, National Cancer Institute, Kyiv, Ukraine.
| | - Valerii B Orel
- Bogomolets National Medical University, Medical Faculty 2, Kyiv, Ukraine.
| | | | - Anatoliy Burlaka
- R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Kyiv, Ukraine.
| | - Sergey Lukin
- R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Kyiv, Ukraine.
| | | |
Collapse
|